Finance

Lists
317450:KRX
Myung In Pharm Co Ltd
42 150,00 KRW
+1,93%
(+800,00) 1D
19 ოქტ, 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 317450...
Open
40 450 KRW
High
42 150 KRW
Low
40 450 KRW
Mkt. cap
615,39 მლრ.
Avg. vol.
11,16 ათ.
Volume
9,39 ათ.
Dividend
2,37%
Quarterly dividend
250 KRW
Ex-dividend date
28 აგვ. 2026
P/E ratio
4,46
52-wk high
97 400 KRW
52-wk low
39 100 KRW
EPS
9 453 KRW
Shares outstanding
14,60 მლნ.
Open
40 450 KRW
High
42 150 KRW
Low
40 450 KRW
Mkt. cap
615,39 მლრ.
Avg. vol.
11,16 ათ.
Volume
9,39 ათ.
Dividend
2,37%
Quarterly dividend
250 KRW
Ex-dividend date
28 აგვ. 2026
P/E ratio
4,46
52-wk high
97 400 KRW
52-wk low
39 100 KRW
EPS
9 453 KRW
Shares outstanding
14,60 მლნ.
News stories
From web sources and news partners
About Myung In Pharm Co Ltd
CEOლი ჰანგ მიუნგ | Kim Jae-hyuk | კო დონგ-კიო
Employees-
Foundedაპრ 1985
Headquarters-
SectorPharmaceutical industry
Websitemyunginph.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
72,70 მლრდ.
72,09 მლრდ.
72,14 მლრდ.
76,11 მლრდ.
Cost of goods sold
28,31 მლრდ.
28,44 მლრდ.
27,56 მლრდ.
27,73 მლრდ.
Cost of revenue
28,31 მლრდ.
28,44 მლრდ.
27,56 მლრდ.
27,73 მლრდ.
Research and development expenses
1,37 მლრდ.
1,42 მლრდ.
1,10 მლრდ.
2,20 მლრდ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,79 მლრდ.
17,14 მლრდ.
17,47 მლრდ.
17,72 მლრდ.
Operating expense
22,48 მლრდ.
19,98 მლრდ.
19,47 მლრდ.
20,77 მლრდ.
Total operating expenses
50,78 მლრდ.
48,42 მლრდ.
47,03 მლრდ.
48,49 მლრდ.
Operating income
21,91 მლრდ.
23,67 მლრდ.
25,11 მლრდ.
27,61 მლრდ.
Other non operating income
206,58 მლნ.
15,97 მლნ.
446,90 მლნ.
93,97 მლნ.
EBT including unusual items
24,11 მლრდ.
26,79 მლრდ.
30,04 მლრდ.
31,82 მლრდ.
EBT excluding unusual items
24,11 მლრდ.
26,77 მლრდ.
30,04 მლრდ.
31,82 მლრდ.
Income tax expense
5,56 მლრდ.
3,53 მლრდ.
7,31 მლრდ.
7,50 მლრდ.
Effective tax rate
23,05%
13,20%
24,32%
23,57%
Other operating expenses
614,50 მლნ.
533,43 მლნ.
318,66 მლნ.
288,62 მლნ.
Net income
18,55 მლრდ.
23,25 მლრდ.
22,73 მლრდ.
24,32 მლრდ.
Net profit margin
25,51%
32,25%
31,51%
31,96%
Earnings per share
-
-
-
-
Interest and investment income
1,72 მლრდ.
3,26 მლრდ.
3,55 მლრდ.
3,54 მლრდ.
Interest expense
-57,80 მლნ.
-55,11 მლნ.
-54,73 მლნ.
-56,49 მლნ.
Net interest expenses
1,67 მლრდ.
3,20 მლრდ.
3,50 მლრდ.
3,48 მლრდ.
Depreciation and amortization charges
636,54 მლნ.
648,53 მლნ.
612,05 მლნ.
617,68 მლნ.
EBITDA
24,47 მლრდ.
26,18 მლრდ.
27,62 მლრდ.
30,19 მლრდ.
Gain or loss from assets sale
904,00 ათ.
-21,89 მლნ.
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები